Cargando…
Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo
Background. None of treatment options for Cholangiocarcinoma (CCA), including surgery, adjuvant radiotherapy and chemotherapy, and ultimately liver transplantation, have been shown to substantially improve the survival rate in patients with CCA. Valproic acid (VPA), a histone deacetylase inhibitor,...
Autores principales: | Wang, Bing, Yang, Rui, Wu, Yue, Li, Hongbo, Hu, Zouxiao, Chen, Yongjun, Zou, Shengquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845332/ https://www.ncbi.nlm.nih.gov/pubmed/24324485 http://dx.doi.org/10.1155/2013/374593 |
Ejemplares similares
-
Decitabine inhibits the cell growth of cholangiocarcinoma in cultured cell lines and mouse xenografts
por: WANG, BING, et al.
Publicado: (2014) -
Sodium Valproate Induces Cell Senescence in Human Hepatocarcinoma Cells
por: An, Hong-Mei, et al.
Publicado: (2013) -
MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b
por: Yang, Rui, et al.
Publicado: (2014) -
Sodium Valproate-Induced Chromatin Remodeling
por: Mello, Maria Luiza S.
Publicado: (2021) -
Sodium valproate suppresses abnormal neurogenesis induced by convulsive status epilepticus
por: Wu, Peng, et al.
Publicado: (2019)